<DOC>
	<DOCNO>NCT01085526</DOCNO>
	<brief_summary>The trial randomize prospective study examine effect subcutaneous immunotherapy adaptive immune system . The trial include 30 participant randomized treatment control group . The effect measure change basophil activity biology well change plasma cell treatment . Clinical outcome assess QoL questionnaire clinical test . Hypotheses : - change plasma cell correlate change immunoglobulin effector cell response - reduction inflammation due SCIT influence effector cell responses - change paraclinical measurement related clinical finding</brief_summary>
	<brief_title>Changes Specific Immunoglobulin Blood Basophil Activity During Subcutaneous Immunotherapy Allergic Rhinitis</brief_title>
	<detailed_description>The investigator recruit 30 participant , randomize receive SCIT ( 24 ) treatment ( 6 ) The follow measure - development immunoglobulin response - plasma cell updosing phase - change basophil activity updosing maintenance treatment - subtyping allergic sensitization - clinical outcome quality life - change mast cell nasal mucosa - change cell biology basophil</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>rhinoconjunctivitis due grass pollen allergy positive skin prick test nasal allergen challenge test grass pollen extract severe comorbidity , severe asthma , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>basophil activity</keyword>
	<keyword>plasma cell</keyword>
	<keyword>IgE</keyword>
	<keyword>IgG1</keyword>
	<keyword>IgG4</keyword>
	<keyword>mast cell</keyword>
	<keyword>IgE receptor</keyword>
	<keyword>allergic rhinoconjunctivitis</keyword>
	<keyword>grass pollen allergy</keyword>
</DOC>